- Open Access
A passport to neurotransmitter identity
Genome Biology volume 10, Article number: 229 (2009)
Comparison of a regulatory network that specifies dopaminergic neurons in Caenorhabditis elegans to the development of vertebrate dopamine systems in the mouse reveals a possible partial conservation of such a network.
The human brain is the most complex vertebrate 'organ', consisting of roughly 10-100 billion neurons each with a unique identity in terms of neurotransmitter phenotype, anatomical location and connections to other neurons. One of the quests in genome biology is to understand the principles by which the human genome with its limited number of genes generates such highly diverse and yet precisely connected sets of neurons. Addressing a similar issue in the much simpler nervous system of the nematode Caenorhabditis elegans, a recent paper in Nature by Flames and Hobert  has revealed a potentially conserved regulatory logic underlying the terminal differentiation of dopaminergic neurons - neurons that secrete the neurotransmitter dopamine.
Specification of neuronal neurotransmitter type
C. elegans has a well-defined nervous system of 302 neurons in which 118 neuronal types can be distinguished. Six pairs of neurons, each originating from four separate lineages, use dopamine as a neurotransmitter. Flames and Hobert's starting point in delineating the mechanism by which these different neurons acquire the components for dopaminergic neurotransmission is the concept that the genes required in a functional pathway may be coordinately activated by a single or limited number of transcription factors acting on shared cis-regulatory elements. This basic concept has been discussed for more than 30 years using terms such as 'realizator genes' , 'neuron-type selector genes'  and 'post-mitotic selector genes'  to describe these putative sets of coordinately regulated genes. The idea has more recently been re-formulated by Hobert  using the terms 'terminal selector genes' (for the transcription factors involved), 'terminal gene batteries' (the genes making up the pathway, on which the transcription factors act), and 'terminal selector motifs' (the shared cis-elements). The experimental investigation of this concept in the differentiation of dopaminergic neurons in C. elegans by Flames and Hobert  has proved extremely successful, revealing the regulatory codes for the dopamine pathway in this animal.
Using green fluorescent protein (GFP) reporters, Flames and Hobert dissected the cis-regulatory regions of genes operating in dopamine synthesis, release and re-uptake. Through systematic analysis of these regions they find that genes for tyrosine hydroxylase (TH, cat-2), GTP cyclohydrolase (GTPCH, cat-4), amino-acid decarboxylase (AADC, bas-1), the vesicular monoamine transporter (VMAT, cat-1), the dopamine transporter (DAT, dat-1), and also for two dopamine-associated ion channels (asic-1 and trp-4), share a common element, dubbed the 'DA motif'. This is a predicted binding site for transcription factors of the ETS family. By testing C. elegans mutants that lacked each of the ten ETS transcription factors found in this animal, they retrieved AST-1 as the factor responsible for acting on the DA motif in all types of dopaminergic neurons in C. elegans .
Loss- and gain-of-function studies defined ast-1 as necessary and sufficient for the induction and maintenance of the dopaminergic identity of these neurons (Figure 1). In the ast-1 loss-of-function mutant, the expression of all five dopamine-pathway genes was virtually lost, whereas ectopic induction of ast-1 via transgenesis could induce dat-1 and cat-2. The DA motif seems to function in C. elegans as a cell-lineage-independent genomic passport given to a set of genes that, when stamped by the ETS transcription factor AST-1, are permitted entrance to the terminal differentiation pathway in order to specify the dopaminergic identity of neurons.
The authors  then went on to test the conservation of this regulatory mechanism in the mouse, an organism with a more complex genome and nervous system, by testing the consequence of the knockout of the ETS transcription factor Etv1, the mouse ortholog of AST-1, which is expressed in dopaminergic neurons of the mouse olfactory bulb. The DA motif seems indeed to have a conserved function, as in this system Etv1 acts similarly to AST-1 in regulating the gene for tyrosine hydroxylase. In the mouse, Etv1 not only mediates specification of dopaminergic identity, but is also required for the proliferation and maintenance of bulbar dopaminergic neurons. However, this is only one of multiple dopamine systems in the vertebrate brain, and Flames and Hobert suggest that the others may express different ETS factors that fulfill the same role.
Specification of mouse mesodiencephalic dopaminergic neurons
Given the importance of AST-1 in defining the dopaminergic phenotype in C. elegans, Flames and Hobert speculate that the mouse ETS factor Etv5, which is expressed in mesodiencephalic dopaminergic (mdDA) neurons, may play an important role in defining the dopaminergic pheno type in vertebrate mdDA neurons. This neuronal group is essential for defining mood and movement control. However, there are other candidates for potential terminal selector genes for mdDA neurons. It is well established that Nurr1 (an orphan nuclear hormone receptor) is an essential regulator of the mdDA neuronal phenotype through its activation of the genes Th, Vmat2, Dat, and cRet (which encodes a receptor tyrosine kinase) (for a review, see ). In addition, neuronal maintenance relies on Nurr1 activity because mdDA neurons lacking Nurr1 function are gradually lost, and this loss cannot be attributed to the loss of defined dopaminergic markers.
A second transcription factor with a well-established role in the terminal differentiation of mdDA neurons is the paired-like homeodomain transcription factor Pitx3 (for a review, see ). From knockout studies in mice it is clear that the development of substantia nigra (SNc) neurons, a subset of mdDA neurons, is severely compromised by a lack of Pitx3 expression, as marked by the loss of Th expression . The SNc dopaminergic neurons are the ones chiefly lost in Parkinson's disease. Recent results have shown that the specific dependence of the SNc neuronal phenotype on Pitx3 is due to SNc-specific activation of the gene for aldehyde dehydrogenase 2 (Ahd2) by Pitx3. Ahd2 activity locally generates the small signal molecule retinoic acid, whose signaling is crucial for the activation of Th and the terminal differentiation of SNc neurons . As two different transcription factors are essential to drive Th expression within the mdDA, it is not clear which should be designated as the 'terminal selector gene' or whether both should be. In line with the latter idea, it has recently been established that Nurr1 and Pitx3 interact, and that they regulate histone deacetylase (HDAC) activity through release of the co-repressor Smrt, which in turn regulates activation of the dopamine pathway gene battery, including the genes for amino-acid decarboxylase (AADC) and the dopamine receptor D2 (D2R). This interaction is essential for the development of specific mdDA subsets, such as SNc. The initial finding that Nurr1 regulates most of the dopaminergic gene battery has now been refined to suggest that Pitx3 functions as an essential co-regulator in the Nurr1 gene-activation complex (Figure 1). In conclusion, in the mammalian mdDA system it is very difficult to designate a single terminal selector gene for dopaminergic neurons, especially as other dopamine systems present in the vertebrate central nervous system depend on different factors to drive their dopaminergic phenotype.
The ETS factor Pet-1 and terminal differentiation of serotonergic neurons
In regard to other types of neurons, developing serotonergic neurons, which secrete the neurotransmitter 5-hydroxytryptamine (5-HT, serotonin), express a related, but distinct, gene battery compared with dopaminergic neurons, and depend completely on the ETS transcription factor Pet-1 for their development and differentiation [9–13]. Serotonergic neurons that survive Pet-1 ablation are deficient in expression of the serotonin re-uptake transporter (Sert) and tryptophan hydroxylase (Tph) . Analyses of promoter regions of Sert and Tph have shown consensus binding sites for ETS factors , suggesting that Pet-1 might directly activate transcription of these genes in developing serotonergic neurons. The timing of Pet-1 expression, the presence of binding sites for Pet-1 on many genes of the serotonergic pathway and the Pet-1-dependent terminal differentiation of serotonergic neurons in the vertebrate central nervous system would mark Pet-1 as a terminal selector gene. However, other results hint at an additional dependence on the transcription factors Lmx1b and Nkx2.2 for the full activation of the serotonergic phenotype , indicating that a different level of complexity is involved in the vertebrate central nervous system.
As defined by Flames and Hobert [1, 5], the concept of 'terminal selector genes' is an attractive way to define the role of master transcription factors in the development of specific neuronal populations (Figure 1). As they show, the 'DA motif' as the passport to coordinated gene activation during terminal differentiation of neuronal dopaminergic identity operates beautifully in C. elegans. Such a mechanism may equip invertebrates with the efficient means of creating functional pathways using a single master transcription factor. Vertebrate genomes seem to build on this principle, as illustrated by aminergic and glutamatergic neurons in the mouse brain, but with the increasing level of brain complexity the molecular programming becomes more complicated, involving additional and different transcription factors [4, 6, 12–15]. The findings of Flames and Hobert open a new window for control of passports to neuronal neurotransmitter identity. Let's see which borders in genome biology can be passed with it.
Flames N, Hobert O: Gene regulatory logic of dopamine neuron differentiation. Nature. 2009, 458: 885-889. 10.1038/nature07929.
García-Bellido A: Genetic control of wing disc development in Drosophila. Ciba Found Symp. 1975, 29: 161-182.
Jan YN, Jan LY: Neuronal specification. Curr Opin Genet Dev. 1992, 2: 608-613. 10.1016/S0959-437X(05)80180-7.
Cheng L, Arata A, Mizuguchi R, Qian Y, Karunaratne A, Gray PA, Arata S, Shirasawa S, Bouchard M, Luo P, Chen CL, Busslinger M, Goulding M, Onimaru H, Ma Q: Tlx3 and Tlx1 are postmitotic selector genes determining glutamatergic over GABAergic cell fates. Nat Neurosci. 2004, 7: 510-517. 10.1038/nn1221.
Hobert O: Regulatory logic of neuronal diversity: terminal selector genes and selector motifs. Proc Natl Acad Sci USA. 2008, 105: 20067-20071. 10.1073/pnas.0806070105.
Smidt MP, Burbach JPH: How to make a mesodiencephalic dopaminergic neuron. Nat Rev Neurosci. 2007, 8: 21-32. 10.1038/nrn2039.
Smidt MP, Smits SM, Bouwmeester H, Hamers FPT, Linden van der AJA, Hellemons AJCGM, Graw J, Burbach JPH: Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development. 2004, 131: 1145-1155. 10.1242/dev.01022.
Jacobs FMJ, Smits SM, Noorlander CW, von Oerthel L, Linden van der AJA, Burbach JPH, Smidt MP: Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency. Development. 2007, 134: 2673-2684. 10.1242/dev.02865.
Cheng L, Chen CL, Luo P, Tan M, Qiu M, Johnson R, Ma Q: Lmx1b, Pet-1, and Nkx2.2 coordinately specify serotonergic neurotransmitter phenotype. J Neurosci. 2003, 23: 9961-9967.
Hendricks T, Francis N, Fyodorov D, Deneris ES: The ETS domain factor Pet-1 is an early and precise marker of central serotonin neurons and interacts with a conserved element in serotonergic genes. J Neurosci. 1999, 19: 10348-10356.
Hendricks TJ, Fyodorov DV, Wegman LJ, Lelutiu NB, Pehek EA, Yamamoto B, Silver J, Weeber EJ, Sweatt JD, Deneris ES: Pet-ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron. 2003, 37: 233-247. 10.1016/S0896-6273(02)01167-4.
Iyo AH, Porter B, Deneris ES, Austin MC: Regional distribution and cellular localization of the ETS domain transcription factor, FEV, mRNA in the human postmortem brain. Synapse. 2005, 57: 223-228. 10.1002/syn.20178.
Scott MM, Krueger KC, Deneris ES: A differentially autoregulated Pet-1 enhancer region is a critical target of the transcriptional cascade that governs serotonin neuron development. J Neurosci. 2005, 25: 2628-2636. 10.1523/JNEUROSCI.4979-04.2005.
Morin X, Cremer H, Hirsch M, Kapur R, Goridis C, Brunet J: Defects in sensory and autonomic ganglia and absence of locus coeruleus in mice deficient for the homeobox gene Phox2a. Neuron. 1997, 18: 411-423. 10.1016/S0896-6273(00)81242-8.
Guo S, Brush J, Teraoka H, Goddard A, Wilson S, Mullins M, Rosenthal A: Development of noradrenergic neurons in the zebrafish hindbrain requires BMP, FGF8, and the homeodomain protein soulless/Phox2a. Neuron. 1999, 24: 555-66. 10.1016/S0896-6273(00)81112-5.
MPS is supported by NWO grant no. 865.09.002.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Smidt, M.P., Burbach, J.P.H. A passport to neurotransmitter identity. Genome Biol 10, 229 (2009). https://doi.org/10.1186/gb-2009-10-7-229
- Dopaminergic Neuron
- Terminal Differentiation
- Serotonergic Neuron
- Master Transcription Factor
- Vertebrate Central Nervous System